GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: CE
Neutral $72
up 52.00 %

Celanese Corporation (NYSE: CE) downgraded to Neutral with price target $72 by UBS

Monday,  Nov 16, 2015  2:25 PM ET by Lynn Gilbert

UBS downgraded Celanese Corporation (NYSE: CE) to Neutral with price target $72. Previously, UBS rated Celanese Corporation (NYSE: CE) to Buy with price target
$51 on 01/17/2013, when the stock price was valued at $46.83. Since then, Celanese Corporation's stock price has gained 52% as of 11/16/2015's recent price of $71.19.
If you had followed UBS's previous recommendation on CE, you would have gained 52% of your investment in 1033 days.

Celanese Corporation (Celanese) is an integrated producer of chemicals and advanced materials. It is a producer of acetyl products, which are intermediate chemicals for many industries, as well as a global producer of high performance engineered polymers that are used in a variety of end-use applications. Celanese operates principally through four business segments: Advanced Engineered Materials, Consumer Specialties, Industrial Specialties and Acetyl Intermediates. Advanced Engineered Materials segment develops, produces and supplies a portfolio of high performance technical polymers. Consumer Specialties segment consists of its Acetate Products and Nutrinova businesses. Its Industrial Specialties segment includes its emulsions and AT Plastics businesses. Acetyl Intermediates segment produces and supplies acetyl products. In July 2009, the Company completed the sale of its polyvinyl alcohol business to Sekisui Chemical Co. Ltd.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy